Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Dermatological Medicine
Volume 2019, Article ID 3730915, 3 pages
https://doi.org/10.1155/2019/3730915
Case Report

CD5-Positive Primary Cutaneous Diffuse Large B-Cell Lymphoma-Leg Type

1Department of Pathology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece
2Department of Hematopathology, Evangelismos General Hospital, Athens, Greece
3Department of Hematology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece
4Department of Anatomy-Histology-Embryology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece

Correspondence should be addressed to Alexandra Papoudou-Bai; moc.liamg@iabuoduopapa

Received 31 October 2018; Revised 14 December 2018; Accepted 10 January 2019; Published 16 January 2019

Academic Editor: Jaime A. Tschen

Copyright © 2019 Alexandra Papoudou-Bai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Kempf, D. V. Kazakov, and C. Mitteldorf, “Cutaneous lymphomas: An update. Part 2: B-cell lymphomas and related conditions,” American Journal of Dermatopathology, vol. 36, no. 3, pp. 197–210, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. J. P. Nicolay and M. Wobser, “Cutaneous B-cell lymphomas - pathogenesis, diagnostic workup, and therapy,” JDDG: Journal der Deutschen Dermatologischen Gesellschaft, vol. 14, no. 12, pp. 1207–1224, 2016. View at Publisher · View at Google Scholar
  3. R. Willemze, E. S. Jaffe, G. Burg et al., “WHO-EORTC classification for cutaneous lymphomas,” Blood, vol. 105, no. 10, pp. 3768–3785, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. A. L. Suárez, C. Querfeld, S. Horwitz, M. Pulitzer, A. Moskowitz, and P. L. Myskowski, “Primary cutaneous B-cell lymphomas,” Journal of the American Academy of Dermatology, vol. 69, no. 3, pp. 343.e1–343.e11, 2013. View at Publisher · View at Google Scholar
  5. M. Paulli, M. Lucioni, A. Maffi, G. A. Croci, M. Nicola, and E. Berti, “Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL), leg-type and other: An update on morphology and treatment,” Giornale Italiano di Dermatologia e Venereologia, vol. 147, no. 6, pp. 589–601, 2012. View at Google Scholar · View at Scopus
  6. J. J. Hoefnagel, M. M. S. Mulder, E. Dreef et al., “Expression of B-cell transcription factors in primary cutaneous B-cell lymphoma,” Modern Pathology, vol. 19, no. 9, pp. 1270–1276, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Pham-Ledard, M. Prochazkova-Carlotti, L. Andrique et al., “Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell-like diffuse large B-cell lymphoma,” Modern Pathology, vol. 27, no. 3, pp. 402–411, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Tanaka, R. Ichinohasama, M. Iwasaki, M. Sato, and H. Tagami, “Primary cutaneous B-cell lymphomas in Japan: A report of three cases and a comparison of Japanese and white patients,” Journal of the American Academy of Dermatology, vol. 31, no. 1, pp. 54–60, 1994. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Takahashi, Y. Kazama, H. Shimizu, M. Yoshimoto, M. Tsujisaki, and K. Imai, “De novo CD5-positive diffuse large B cell lymphoma solely presenting as multiple subcutaneous nodules,” Acta Haematologica, vol. 107, no. 4, pp. 230–233, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. T. A. Hembury, B. Lee, R. D. Gascoyne et al., “Primary cutaneous diffuse large B-cell lymphoma: A clinicopathologic study of 15 cases,” American Journal of Clinical Pathology, vol. 117, no. 4, pp. 574–580, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Goto, M. Nishio, T. Endo et al., “Effective in vivo purging with rituximab and autologous peripheral blood stem cell transplantation in a woman with CD5 positive primary cutaneous diffuse large B-cell lymphoma,” European Journal of Haematology, vol. 74, no. 6, pp. 526–528, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. J.-L. Dargent, L. Lespagnard, F. Feoli, L. Debusscher, M. Greuse, and D. Bron, “De novo CD5-positive diffuse large B-cell lymphoma of the skin arising in chronic limb lymphedema,” Leukemia & Lymphoma, vol. 46, no. 5, pp. 775–780, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Valera, S. Epistolio, L. Colomo et al., “Definition of MYC genetic heteroclonality in diffuse large B-cell lymphoma with 8q24 rearrangement and its impact on protein expression,” Modern Pathology, vol. 29, no. 8, pp. 844–852, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Dalloul, “CD5: A safeguard against autoimmunity and a shield for cancer cells,” Autoimmunity Reviews, vol. 8, no. 4, pp. 349–353, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Baglaenko, K. P. Manion, N.-H. Chang, C. Loh, G. Lajoie, and J. E. Wither, “Suppression of autoimmunity by CD5(+) IL-10-producing B cells in lupus-prone mice,” Genes & Immunity, vol. 16, no. 5, pp. 311–320, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Bongioanni, C. Fioretti, R. Vanacore et al., “Lymphocyte subsets in multiple sclerosis A study with two-colour fluorescence analysis,” Journal of the Neurological Sciences, vol. 139, no. 1, pp. 71–77, 1996. View at Publisher · View at Google Scholar · View at Scopus